Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2004;328:1076 (1 May), doi:10.1136/bmj.328.7447.1076-b
| The first 150 words of the full text of this article appear below. |
EDITORJenkins et al describe the pooled data for the risk of aspirin induced asthma, and by implication all asthma induced by non-steroidal anti-inflammatory drugs (NSAIDs).1 NSAIDs are an important group of medicines in the treatment of acute pain after injury. Not all patients are, however, able to tolerate them because of respiratory or gastrointestinal side effects.
It is accepted that more patients are being diagnosed as asthmatic, so is it true that NSAIDs can be prescribed to fewer patients? The trials that were pooled for the meta-analysis had differing selection criteria. It would be fair to comment that the population used for the study is one where the asthma is more severeasthma clinics and admissions for acute exacerbations. It would be fair to say that most patients with asthma are managed in the community without any problems. To say that anyone under 40 should have a witnessed trial
Robert D Southward, consultant in accident and emergency medicine
University Hospital of Hartlepool, Hartlepool TS24 9AH robertdougal.southward@nth.nhs.uk